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Abstract
Chemoprevention has become an important area in cancer research due to the failure of current therapeutic 
modalities. Epidemiological and preclinical studies have demonstrated that nutrition plays a vital role in the etiology of 
cancer. This study was conducted to determine the chemopreventive effects of germinated brown rice (GBR) in rats 
induced with colon cancer. GBR is brown rice that has been claimed to be richer in nutrients compared to the common 
white rice. The male Sprague Dawley rats (6 weeks of age) were randomly divided into 5 groups: (G1) positive control 
(with colon cancer, unfed with GBR), (G2) fed with 2.5 g/kg of GBR (GBR (g)/weight of rat (kg)), (G3) fed with 5 g/kg of 
GBR, (G4) fed with 10 g/kg of GBR and (G5) negative control (without colon cancer, unfed with GBR). GBR was 
administered orally once daily via gavage after injection of 15 mg/kg of body weight of azoxymethane (AOM) once a 
week for two weeks, intraperitonially. After 8 weeks of treatment, animals were sacrificed and colons were removed. 
Colonic aberrant crypt foci (ACF) were evaluated histopathologically. Total number of ACF and AC, and multicrypt of 
ACF, and the expression of β-catenin and COX-2 reduced significantly (p < 0.05) in all the groups treated with GBR (G2, 
G3 and G4) compared to the control group (G1). Spearman rank correlation test showed significant positive linear 
relationship between total β-catenin and COX-2 score (Spearman's rho = 0.616, p = 0.0001). It is demonstrated that GBR 
inhibits the development of total number of ACF and AC, and multicrypt of ACF, reduces the expression of β-catenin 
and COX-2, and thus can be a promising dietary supplement in prevention of colon cancer.
Background
Colon cancer develops through a multistage process that
could be recognized at a histopathological level by pro-
gression from mucosa to invasive carcinoma. Colorectal
cancer is becoming increasingly common in Asian coun-
tries while remains the second leading cause of cancer
death in the United States. Approximately 110,000 new
cases are diagnosed each year [1]. Epidemiological data
suggest that diet is a major factor in the etiology of colon
cancer [2].
GBR is brown rice, which has been soaked in water for
up to a day and has a germ of approximately 1 mm long.
During germination, nutrients in the brown rice change
drastically. Nutrients that increase in content include γ-
amirobutyric acid (GABA), dietary fiber, inositols, ferulic
acid, phytic acid, tocotrienols, magnesium, potassium,
zinc, γ-oryzanol, and prolylendopeptidase inhibitor [3].
According to Ken'ichi, germinated brown rice contained
more total ferulic acid (126%), total dietary fiber (145%),
soluble dietary fiber (120%) and insoluble dietary fiber
(150%) compared to the brown rice [4]. Aberrant crypt
foci (ACF) are a cluster of colorectal crypts with abnor-
mal morphology that was first discovered in mice treated
with azoxymethane [5]. In 1991, Prestlow has proposed
that aberrant crypt foci in methylene blue-stained of
colon as putative preneoplastic lesions that could be
found in rodents as well as in human [6]. ACF were iden-
tified in rat colon, appearing a few weeks after treatment
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with carcinogen and becoming larger with time, with
more marked nuclear atypia or dysplasia [7]. The aber-
rant crypts stained more darkly, were larger and had a
thicker epithelial lining and a larger pericryptal zone than
normal crypts [8]. Further investigation had established
ACF as biomarkers of cancer risk in azoxymethane
(AOM)-treated in rodents [9].
β-catenin, which was originally a cadherin-binding pro-
tein, has recently been proven to function as a transcrip-
tional activator when it formed a complex with members
of the T cell factor (Tcf) family of DNA binding protein
[10,11]. Activation of the β-catenin-Tcf pathway results in
the accumulation of β-catenin in the cytosol and nucleus
[11,12]. Target genes of the β-catenin-Tcf pathway were
determined to be growth-promoting genes, which sug-
gest that β-catenin-Tcf is an oncogenic pathway. It is also
known that β-catenin levels are regulated by the degrada-
tion of the protein through the ubiquitin-proteasome
pathway [13]. Mutation in the Adenomatous polyposis
coli (APC) or β-catenin genes, are associated with major-
ity of human and rat colon tumors [13,14] and were
proved to repress the degradation of the protein and gen-
erate β-catenin accumulations [15], which leads to activa-
tion of the oncogenic β-catenin-Tcf pathway. Excessive β-
catenin protein has been shown in many colon cancers of
rats and human [13]. Yamada et al. [16] had demon-
strated that β-catenin gene mutations and accumulations
of the protein are involved in the initial stage of colon car-
cinogenesis induced in rats by AOM.
Cyclooxygenase (COX) catalyses the rate limiting step
in the conversion of arachidonic acid to prostaglandin H2
(PGH2), which is further metabolized to form PGD2,
PGE2, PGF2α, PGI2, thromboxanes A2 and leukotrienes
[17-19]. COX exists in at least two different isoforms
COX-1 and COX-2, which have a high degree of struc-
tural and enzymatic homology but pharmacologically dis-
tinct [20]. COX-2 is an inducible enzyme produced
mainly in inflammatory cells, inflammatory sites and col-
orectal carcinomas [19,21]. β-catenin-Lef (lymphoid
enhancer-binding factor) complex acts as a crucial regu-
lators of COX-2 mRNA, protein and PGE2 expression
[22]. It has been demonstrated that the COX-2 5' regula-
tory region contains the consensus Lef-1 binding motive,
thus supporting the hypothesis that COX-2 expression is
mediated through Wnt (the name derived from lnt-1 and
Drosophila wingless) signalling pathway. In animal stud-
ies, COX-2 mRNA and protein level in adenomatous tis-
sue is three fold higher than normal mucosa of the same
Min mouse bearing a mutation in the APC  gene and
markedly elevated in carcinogen-induced rat colonic
tumours [23,24].
Studies have led to the recognition of the importance of
COX-2 in colorectal tumorigenesis and in the develop-
ment of intestinal neoplasms in genetically manipulated
animal models, in which overexpression of COX-2 in
colon cancer as well as its established cell lines is fre-
quently demonstrated [25]. Tsujii et al. has also demon-
strated that COX-2 overexpression enhances
neovascularization thus conferring survival advantage of
colon cancer cells [26].
Continuous intake of germinated brown rice has been
predicted to prevent cancer of colon, but there is no sci-
entific proof on that, as yet [27]. The goal of this study
was to determine the chemopreventive properties of ger-
minated brown rice in rat induced with colon cancer.
Materials and methods
Animals, diets, carcinogen and GBR
Five-week-old male Sprague Dawley rats were purchased
from the Faculty of Veterinary Medicine, UPM. Animal
Care and Use Ethic was obtained from the Animal Care
and Use Committee (ACUC), Faculty of Medicine and
Health Sciences, Universiti Putra Malaysia (ACUC No;
UPM/FPSKPADS/FO1-00172). AOM was purchased
from Sigma Chemical Company, St. Louis USA. The rats
were housed in plastic cages (2 rats per cage) with wood-
chip bedding in a well ventilated room at room tempera-
ture, 29-32°C; 50-60% relative humidity; 12 hours light
and darkness cycle. Hygienic conditions were maintained
by weekly changes of the woodchip beds. GBR was kindly
supplied by the Laboratory of Molecular Biomedicine,
Institute of Bioscience, Universiti Putra Malaysia. Briefly,
GBR was soaked at 32°C for 24 hours until germinated.
Subsequently, GBR was ground using Rotary type grind-
ing and pulverizing machines (RT-34) to produce powder.
The GBR powder was dissolved in distilled water accord-
ing to the dosage/treatment.
Experimental procedures
Following a one week of acclimatization, the male
Sprague Dawley rats were divided into five groups (n =
10), which were (G1) positive control (with colon cancer,
unfed with GBR), (G2) fed with 2.5 g/kg of GBR (GBR (g)/
weight of rat (kg), (G3) fed with 5 g/kg of GBR, (G4) fed
with 10 g/kg of GBR and (G5) negative control (without
colon cancer, unfed with GBR). At 6 weeks of age, the ani-
mals in groups 1-4 were injected with AOM intraperito-
nially (i.p) (15 mg/kg body weight) once weekly for two
weeks. At 9 weeks of age, rats in group 2-4 were treated
with GBR at 2.5 g/kg, 5 g/kg and 10 g/kg (weight of GBR
(g)/weight of rat (kg)) by oral administration via gavage
once daily for 8 weeks. The animals were fed with com-
mercial basal diet in the form of pellet throughout the
experimental period. The GBR free animals were given
distilled water (that has been used to dissolve GBR prior
to treatment) via gavage throughout the experimental
period. Body weight of the rats was recorded weekly until
the termination of the study. Upon termination, all ani-Latifah et al. Nutrition Journal 2010, 9:16
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mal were sacrificed by decapitation under chloroform
anesthesia. Colon was removed and cut longitudinally.
The colon was washed with phosphate-buffered saline,
fixed in 10% of formalin and stained with hematoxylin
and eosin. The total number of ACF and AC per colon
was recorded.
Immunohistochemical analysis of β-catenin and COX-2
The paraffin embedded sections were heated at 60°C for
60 min, deparaffinized in xylene, and rehydrated through
graded alcohol at room temperature. Four-μm-thick sec-
tion obtained from whole part of the colon of each rat
was treated with 3% of bovine serum albumin (BSA) for
one hour at room temperature to block the non-specific
antigen sites, and subsequently incubated with primary
antibody for another one hour. The expression of β-
catenin was determined using a monoclonal antibody
raised against a peptide corresponding to the C-terminus
of mouse β-catenin (Transduction Laboratories, Lexing-
ton, KY) (1:200). COX-2 protein expression was detected
by tissue culture supernatant of rabbit IgG (Neomarkers,
Fremont, CA) raised against a synthetic peptide from C-
terminus of rat COX-2 (1:100). All the antibodies were
diluted in antibody diluent (LabVision, UK). Streptavidin-
biotin complex peroxidase kit (Code No. K0690, LSAB®+
Kit, DAKO, USA) was used as the secondary antibody.
The peroxidase activity was developed by incubating the
slides in the substrate 3,3'-diaminobenzidine (DAB) (Lab-
Vision, UK). A semi-quantitative scoring system adopted
from Rajnakova et al. [28] was used to score the staining
by antibody against β-catenin and COX-2. The immuno-
reactive score was determined by summing up the extent
and intensity of the staining (score = extent+intensity) of
five fields, randomly selected from each section of colon
per rat. The extent of positive cells was evaluated using
the following scale: 0, no staining of the mucosal epithe-
lial cells in any field; 1+, <25% of the epithelium stain pos-
itive; 2+, 25-50% stain positive; 3+, 50-75% stain positive;
and 4+, >75% stain positive. As for the strength of inten-
sity of staining, evaluation was based on the following
scale; 0, no staining of the epithelial cells; 1+, mild stain-
ing; 2+, moderate staining; and 3+, intense staining. The
maximum score after summation was 7 and the mini-
mum was 0.
Statistical analysis
Difference in ACF and AC incidences among rats fed
with GBR was compared by One Way ANOVA, and dif-
f e r e n c e  i n  b o d y  w e i g h t  w a s  a n a l y z e d  b y  T w o  W a y
ANOVA. Duncan method for multiple comparisons was
used to determine the significance among each group.
Non-parametric Kruskal-Wallis test and Mann-Whitney
U-test were used to compare the expression of β-catenin
and COX-2. Correlation between the two proteins was
analyzed by Spearman rank correlation test. The mean
score was calculated by summation of the extent and
intensity of the staining (score = extent+intensity) of five
field, randomly selected from each section of colon/rat.
The data were presented as mean ± SEM.
Results
There was a significant difference (p < 0.05) in the body
weight between the groups treated with GBR and the
control (G1) (data not shown). The effect of GBR on the
incidence of ACF is shown in Table 1 and Figure 1. It indi-
cates that there was a significant reduction (p < 0.05) in
the total number of ACF and AC, and multicrypt of ACF
per colon in all the groups treated with GBR (G2, G3 and
Figure 1 Effect of different percentage of germinated brown rice on number of aberrant crypt foci (ACF) after 8 weeks of treatment. The 
data were analyzed by using one way ANOVA and the values are expressed as mean ± S.E.M. p < 0.05 was considered significant.
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G4) compared to the control group (G1). Reduction in
the total number of ACF and AC, and multicrypt of ACF
with increase in the percentage of GBR was observed but
yet insignificant.
All tissue samples from G1 showed intense and het-
erogenous β-catenin immunoreactivity throughout the
colon epithelia (Figure 2). In samples from the treatment
groups (G2, G3 and G4), heterogenous expression of β-
catenin was also observed. None of the tissue samples
from G5 showed expression of β-catenin. There was no
localization of β-catenin at cell membrane, cytoplasm
and nucleus of the colon epithelial cells. The median
scores of β-catenin expression and mean ranks by
Kruskal-Wallis test are shown in Table 2. Comparison
between groups by Mann-Whitney U-test showed signifi-
cant difference (p  = 0.0001) in the expression of β-
catenin.
The colon epithelia from G1 showed more intense
immunoreactivity of COX-2 indicating significant
increase (p = 0.0001) in the expression of COX-2 com-
pared to the treatment groups (G2, G3 and G4). Weak,
diffused and heterogenous expression of COX-2 was
observed in the tissue samples from G5 (Figure 3). Local-
ization of COX-2 could be observed at nuclear membrane
and cytoplasm of some of the colon epithelial cells. The
median scores of COX-2 expression and mean ranks are
shown in Table 3. Comparison between groups by Mann-
Whitney U-test showed significant difference (p  =
0.0001) in the expression of COX-2.
Spearman rank correlation test showed significant pos-
itive linear relationship between total β-catenin and
COX-2 score (Spearman's rho = 0.616, p = 0.0001).
Discussion
This study demonstrates that treatment with 2.5 g/kg, 5
g/kg and 10 g/kg of GBR (weight of GBR (g)/weight of rat
(kg)) significantly suppressed the total number of ACF,
AC and multicrypt of ACF per colon, yet was insignifi-
cant among the GBR-treated groups. It is postulated that
the chemopreventive effects of GBR was dose-indepen-
dent. The ACF was found to consist of 1, 2, 3, 4 or more
crypts. It is believed that the number of crypts increases
with time due to crypt multiplication or branching [7].
The crypts reproduce themselves by a fission mechanism
[ 2 9 ] .  H o w e v e r ,  t h e  n u m b e r  o f  A C F s  c o r r e l a t e s  p o o r l y
with cancer risk. It is the crypt multiplicity that is more
predictive of malignant transformation [30]. It has been
hypothesized that many ACFs regress and only larger foci
or lesions progress to cancer [9]. Therefore, GBR seems
to be a potential agent to inhibit the progression of colon
cancer since the number of larger foci (4 or more crypts)
was found to be significantly less in all groups treated
with it compared to the control group (Figure 1).
All tissue samples from G5, which represent the normal
colon tissue did not show β-catenin immunoreactivity
Figure 2 Immunohistochemical staining of positive control (G1) 
tissue using antibody against β-catenin. Intense immunoreactivity 
was present throughout the epithelial cells, in cell membrane and cy-
toplasm (100× magnification) (1). Immunohistochemical staining of 
G2 tissue using antibody against β-catenin showing less intense stain-
ing (100× magnification) (2). Immunohistochemical staining of nega-
tive control (G5) tissue using antibody against β-catenin. (100× 
magnification)(3).
 
1  2 3
Table 1: Effect of germinated brown rice on AOM-induced ACF formation in male Sprague Dawley rats
No. of ACF containing
Treatment ACF/colon 1 crypt 2 crypts 3 crypts 4 or more 
crypts
Total aberrant 
crypt
AOM + basal diet
(G1)
41.50
± 3.008
16.00
± 0.730
15.67
± 1.520
4.00
± 0.894
5.50
± 1.310
81.30
± 7.745
AOM + basal diet + 2.5 g/kg of GBR
(G2)
28.60
± 1.720a
12.20
± 1.241
10.60
± 1.208a
2.20
± 0.200
3.40
± 0.678
53.60
± 3.970a
AOM + basal diet + 5 g/kg of GBR
(G3)
25.50
± 2.327a
12.00
± 2.160
9.50
± 0.646a
2.75
± 0.250
1.25
± 0.479a
44.25
± 2.750a
AOM + basal diet +10 g/kg of GBR
(G4)
24.40
± 1.806a
10.40
± 1.123a
8.40
± 0.927a
2.20
± 0.374
2.80
± 0.860
44.00
± 4.159a
Basal diet alone (G5) 0000 0 0
Values are expressed as mean ± SEM. Mean with the a superscript are significant p < 0.05 as compared to positive control, G1Latifah et al. Nutrition Journal 2010, 9:16
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(Figure 2). There was no localization of stain at cell mem-
brane, cytoplasm and nucleus of epithelial cells and gob-
let cells. This may indicate that the level of β-catenin in
the normal colon mucosa is too low to be detected by this
method of immunohistochemistry (IHC). In contrast,
previous studies by Hong [31] reported that all the nor-
mal adjacent tissue of human colorectal sample showed
β-catenin immunoreactivity in the plasma membrane at
cell to cell border, and cytoplasm of the epithelial cells
and goblet cells, but no nuclear staining was found. Taka-
hashi et al. [32] also showed localization of β-catenin at
membranes of cell-to-cell borders in normal colon epi-
thelial cells of male F344 rats. The divergence in our
staining result may be caused by inter-species and inter-
strain variation between the Sprague Dawley rats and the
other samples (human and other breeds of rats).
In the tissues of positive control group (G1), where
colon carcinogenesis was initiated by injection of AOM
but no treatment with GBR was given, intense β-catenin
stain (immunoreactivity in the cytoplasm of epithelial
cells is prominent) was observed, representing much
higher level of β-catenin (Figure 2). The intensity of the
brown stain is variable, where some cells exhibit greater
intensity at the cell membrane compared to the cyto-
plasm, while other cells lost or have reduced brown stain
at the cell membrane, thus appearing that the cytoplasm
compartment has more localization of β-catenin. Overall
scoring showed that the epithelial cells of G1, which was
shown to have the highest number of aberrant crypt foci
(ACF) among all groups (Table 1), has the highest score
in the evaluation of immunohistochemical staining of β-
catenin compared to other groups.
According to Goss and Groden [33], β-catenin binds to
the cytoplasmic tail of α-catenin and E-cadherin and
indirectly to the cytoskeleton. It may dissociate from
them and enters cytoplasm as free unbound β-catenin.
Since β-catenin is an important Wnt signaling pathway
activator, its level in the normal tissue is constantly regu-
lated by APC, axin and glycogen synthase kinase-3β
(GSK-3β) complex that targets its rapid degradation in
the cytoplasm to prevent translocation of β-catenin into
the nucleus to promote transcription of various target
genes [31].
Mutations in β -catenin, APC, axin and GSK-3β may
result in the inability of the complex to phosphorylate β-
catenin, resulting in failure of ubiquitination; whereas E-
cadherin  mutation can cause dissociation of β-catenin
from the complex, releasing free β-catenin into the cyto-
plasm. This explains loss or reduced β-catenin protein at
the cell-to-cell borders but an over-expression in the
cytoplasm of the G1 tissues.
In the treatment groups (G2, G3, and G4), heteroge-
nous expression of β-catenin was observed in the cell
membrane and cytoplasm compartment. Nevertheless,
all the three treatment groups showed significant
decrease in β-catenin expression compared to G1. This
indicates that GBR has the potential of reducing the
expression of β-catenin. It is postulated that GBR is a nat-
ural chemopreventive agent which acts through pathway
involving β-catenin.
Tissue samples from G5, which represent the normal
colon tissue showed some degree of COX-2 immunoreac-
Table 2: Median scores and mean ranks of β-catenin expression according to group
Group Median score* Mean score
AOM + basal diet
(G1)
6.00a 300.83
AOM + basal diet + 2.5 g/kg of GBR
(G2)
5.00b 223.68
AOM + basal diet + 5 g/kg of GBR
(G3)
5.00b 222.94
AOM + basal diet +10 g/kg of GBR
(G4)
4.00c 184.94
Basal diet alone (G5) 0.00d 39.50
*Median scores with different superscript are significantly different at p < 0.05 (Mann-Whitney U-test).
Figure 3 Immunohistochemical staining of positive control (G1) 
tissue using antibody against COX-2. Immunoreactivity was present 
throughout the epithelial cells (100× magnification) (1). Immunohis-
tochemical staining of G2 tissue using antibody against COX-2 show-
ing weaker staining compared to G1 (100× magnification) (2). 
Immunohistochemical staining of negative control (G5) tissue using 
antibody against COX-2 (100× magnification)(3).
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tivity, where the expression of COX-2 was found to be
weak, diffused and heterogenous (Figure 3). Lack of
expression of COX-2 in tissue samples from G5 indicates
that most normal colonic cells were not undergoing
inflammation. However there was still a score of 3 as to
indicate that inflammation does exist in normal condition
but at a very slow rate. COX-2 is known to be an induc-
ible enzyme that plays an important role in induction of
pain and inflammation [34]. Localization of COX-2 could
be seen mainly at the cytoplasm of colon epithelial cells,
and some cells also showed clear nuclear membrane
stain. No nuclear staining was observed. Similarly, Tomo-
zawa  et al. [35] and Takahashi et al. [36] have also
reported COX-2 expression in normal rat colon mucosa
using IHC method.
In the tissues of G1, the colon epithelia showed much
greater COX-2 immunoreactivity compared to all other
groups (Figure 3). The staining was also heterogenous
throughout the tissues, mostly in the cytoplasm. No
nuclear staining was found. Many studies reported well-
documented observation of COX-2 expression in colonic
tumour. For example, Tomozawa et al. [35] and Takahashi
et al. [36] have reported positive immunoreactivity in
cytoplasm and nuclear membranes of tumour cells. The
staining pattern in the treatment groups is similar , but
with apparent reduction in both intensity and percentage
of positive cell, compared to G1. This shows that GBR
prevents colon carcinogenesis by down-regulating the
COX-2 expression.
As for the comparison among the treatment groups,
there were significant differences (p = 0.0001) between
G2 and G3, and between G2 and G4. This indicates that
the expression of COX-2 decreased with increase in the
concentration of GBR. APC, β-catenin, axin, and GSK-3β
mutations can cause increased expression of β-catenin in
the cytoplasm and nucleus of colorectal carcinoma,
which leads to Wnt pathway activation. Since COX-2 may
be a downstream target of Wnt signaling pathway, COX-2
gene is upregulated and COX-2 expression is increased in
tumour cells [37,38].
Spearman rank correlation test showed a statistically
positive linear relationship between β-catenin and COX-
2 scores. This is in accordance with findings by Kawasaki
et al. [39] that showed positive correlation of COX-2 over
expression with cytoplasmic β-catenin expression. Thus,
indicating a possible link between COX-2 and the Wnt
signaling pathway [40]. COX-2 has been shown to acti-
vate β-catenin through prostaglandin E2 and G protein-
coupled receptor EP2 (E prostanoid 2) [41]. A study by
Lee and Jeong has shown that β-catenin stabilizes COX-2
mRNA by interacting with AU-rich elements in a 3'
untranslated region [42]. These findings suggest the exis-
tence of a positive feedback loop between β-catenin and
COX-2. Therefore, GBR might have suppressed β-catenin
expression through regulation of COX-2 or vice versa. It
is also possible that GBR regulates expression of both
proteins simultaneously.
This study indicates that GBR possesses good chemo-
preventive effects, more likely due to the nutritional com-
ponents that are increasing in content following the
process of germination such as phytic acid (IP6), ferulic
acid, inositol and dietary fiber [4]. It has been reported
that inositol hexaphosphate (IP6) reduced the carcino-
gen-induced large bowel cancer and inhibited growth of
transplanted tumors [43]. However, the mechanism by
which IP6 exerts chemopreventive is not completely
understood. In general, IP6 is rapidly absorbed by cells
and metabolized to lower phosphates and inositol [44].
Both IP6 and its lower phosphates have metal chelating
activity and may interfere with tumor formation by sup-
pressing metal catalyzed oxidation of fats. It regulates the
cell cycle to block uncontrolled cell division and force
malignant cells either to differentiate or to undergo apop-
tosis [45]. Alternatively, IP6 may block the activity of key
enzyme(s) affecting cell proliferation. One enzyme candi-
date is PI-3kinase which plays a central role in signal
Table 3: Median scores and mean ranks of COX-2 expression according to group
Group Median score* Mean score
AOM + basal diet
(G1)
6.00a 324.16
AOM + basal diet + 2.5 g/kg of GBR
(G2)
5.00b 241.72
AOM + basal diet + 5 g/kg of GBR
(G3)
4.00c 182.25
AOM + basal diet +10 g/kg of GBR
(G4)
4.00c 170.04
Basal diet alone (G5) 3.00d 54.15
*Median scores with different superscript are significantly different at p < 0.05 (Mann-Whitney U-test).Latifah et al. Nutrition Journal 2010, 9:16
http://www.nutritionj.com/content/9/1/16
Page 7 of 8
transduction and cell transformation triggered by growth
factor or tumor promoter. IP6 has been reported to
inhibit PI-3 kinase activity in vitro [46]. In addition, the
antioxidant properties of IP6 may also contribute to its
antineoplastic activity [47]. Ferulic acid inhibits the
growth of colonic ACF and suppresses the progression of
preneoplastic to malignant neoplasia. The suppression of
metabolic activation and enhancement of detoxification
may become one of the mechanisms for chemopreventive
action of ferulic acid [48].
As functional food component, Shamsuddin [44] has
reported that inositol plays a role in suppressing tumor
formation. Meanwhile, Alabaster [49] has found that the
dietary fiber is linked to the prevention of colon carcino-
genesis. A high fiber intake result in a high stool bulk,
which reduces stool transmit time and thus lowers expo-
sure to potential carcinogens [50].
T h i s  f i n d i n g s  s h o w  t h a t  g e r m i n a t e d  b r o w n  r i c e  h a s
chemopreventive properties in rats induced with colon
cancer. The administration of 2.5 g/kg, 5 g/kg and 10 g/kg
of GBR (weight of GBR (g)/weight of rat (kg)) signifi-
cantly reduced the total number of ACF, AC, and multic-
rypt of ACF, and the expression of β-catenin and COX-2
compared to the positive control (without GBR). It is sug-
gested that GBR can be a promising dietary intake for
prevention of human colon cancer.
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